Burkitt's lymphoma laboratory tests

Jump to navigation Jump to search

Burkitt's lymphoma Microchapters


Patient Information


Historical Perspective




Differentiating Burkitt's lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study Of Choice


History and Symptoms

Physical Examination

Laboratory Findings

X Ray Findings




Other Imaging Studies

Other Diagnostic Studies


Medical Therapy


Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Burkitt's lymphoma laboratory tests On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Burkitt's lymphoma laboratory tests

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Burkitt's lymphoma laboratory tests

CDC on Burkitt's lymphoma laboratory tests

Burkitt's lymphoma laboratory tests in the news

Blogs on Burkitt's lymphoma laboratory tests

Directions to Hospitals Treating Burkitt's lymphoma

Risk calculators and risk factors for Burkitt's lymphoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]


Laboratory tests for Burkitt's lymphoma include complete blood count (CBC), blood chemistry studies, immunohistochemistry, HIV blood test, flow cytometric analysis, and cytogenetics.

Laboratory Findings

Laboratory tests for Burkitt's lymphoma include:[1]


  1. Perkins AS, Friedberg JW (2008). "Burkitt lymphoma in adults". Hematology Am Soc Hematol Educ Program: 341–8. doi:10.1182/asheducation-2008.1.341. PMID 19074108.
  2. Ekemen S, Uzay A, Bassullu N, Dikicioglu-Cetin E, Matsuda K, Ince U; et al. (2018). "Does it take three to tango? An unsuspected multimorbidity of CD8+ T cell lymphoproliferative disorder, malaria, and EBV infection". Malar J. 17 (1): 349. doi:10.1186/s12936-018-2497-9. PMC 6173833. PMID 30290813.
  3. 3.0 3.1 Mwanda WO, Orem J, Remick SC, Rochford R, Whalen C, Wilson ML (2005). "Clinical characteristics of Burkitt's lymphoma from three regions in Kenya". East Afr Med J. 82 (9 Suppl): S135–43. PMID 16619689.
  4. Pinisetti S, Nalabolu GR, Uvr C, Tadi DP (2013). "HIV Associated Intra-oral Burkitt's Lymphoma: A Case Report". J Clin Diagn Res. 7 (12): 3088–9. doi:10.7860/JCDR/2013/6715.3862. PMC 3919292. PMID 24551737.
  5. Kretzmer H, Bernhart SH, Wang W, Haake A, Weniger MA, Bergmann AK; et al. (2015). "DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control". Nat Genet. 47 (11): 1316–1325. doi:10.1038/ng.3413. PMC 5444523. PMID 26437030.
  6. McGowan P, Nelles N, Wimmer J, Williams D, Wen J, Li M; et al. (2012). "Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter scoring system". Am J Clin Pathol. 137 (4): 665–70. doi:10.1309/AJCP3FEPX5BEEKGX. PMC 4975158. PMID 22431545.
  7. Grygalewicz, Beata; Woroniecka, Renata; Rymkiewicz, Grzegorz; Rygier, Jolanta; Borkowska, Klaudia; Kotyl, Aleksandra; Blachnio, Katarzyna; Bystydzienski, Zbigniew; Nowakowska, Beata; Pienkowska-Grela, Barbara (2018). "The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS". American Journal of Clinical Pathology. 149 (1): 17–28. doi:10.1093/ajcp/aqx139. ISSN 0002-9173.

Template:Chromosomal abnormalities

Template:WikiDoc Sources